PD-L1 expression by cancer cells is one of the mechanisms of immune response evasion, as it activates immune checkpoint protein PD-1 on cytotoxic CD8+ T lymphocytes and reduces their activity (a phenomenon which is called “exhaustion”) [8]. This evidence concerns the gene CD8A and cancer.